000			02662cam a2200301 i 4500
003			SA-RiNAUS
005			20230530114303.0
008			120117s2012 njua b 000 0 eng d
020			_a9781118149652 (cloth)
040			_aSA-RiNAUS _beng _cSA-RiNAUS _erda
082	0	0	_a615.7040724 _221 _bD A R
100	1		_aDasgupta, Amitava, _d1958- _eauthor. _937396
245	1	0	_aResolving erroneous reports in toxicology and therapeutic drug monitoring : _ba comprehensive guide / _cAmitava Dasgupta.
264		1	_aHoboken, N.J. : _bJohn Wiley & Sons, _c2012.
300			_aviii, 457 pages. : _billustrations ; _c25 cm
504			_aIncludes bibliographical references.
505	0		_aAn introduction to tests performed in toxicology laboratories and methodologies available for such testings -- Challenges in drugs of abuse testing -- False positive results in immunoassays for drugs of abuse testing -- True positive drugs of abuse test results due to prescription and non-prescription drugs -- When toxicology report is negative in a suspected overdosed patient : the world of designer drugs -- Abuse of magic mushroom, peyote cactus and solvent : no readily available laboratory tests -- False positive alcohol tests using breath analyzers and automated analyzers -- Role of laboratory in detecting other poisoning including pesticides, ethylene glycol, and methanol -- Poisoning with warfarin and superwarfarin : what laboratory can do? -- Plant poisoning and clinical laboratory -- Sources of erroneous results in therapeutic drug monitoring due to pre-analytical errors, high bilirubin, hemolysis, and heterophilic antibody -- Interferences in immunoassays used for digoxin monitoring -- Interferences in immunoassays used for monitoring anticonvulsants and usefulness of monitoring free anticonvulsants in certain patients -- Interferences in immunoassays used for monitoring tricyclic antidepressant -- Therapeutic drug monitoring of immunosuppressant drugs : limitations of immunoassays and need for chromatographic methods -- Effect of drug-herb interactions on therapeutic drug monitoring -- Pharmacogenomics and toxicology laboratory -- Approaches for eliminating interference/discordant specimen in therapeutic drug monitoring and drugs of abuse testing.
650		4	_aDrug monitorin _937401
650		4	_aDrugs _xToxicity testing _937397
650		4	_aDrug Monitoring _xmethods _937398
650	2	2	_aFalse Positive Reactions _937399
650		4	_aPharmaceutical Preparations _xanalysis. _92189
650		4	_aSubstance Abuse Detection _xmethods. _937400
942			_2ddc _cNEW
999			_c34030 _d34029